How effective are non-invasive brain stimulation techniques on the symptoms of psychiatric disorders? How far has the field come, and what’s next?
Our panelists respond to questions from our recent live panel discussion, ‘Brain banking: progress, challenges and opportunities’.
In this interview, Prof Wischik discusses his 30 years’ experience in the field, the latest developments at TauRx, and what we can expect from tau research the next 10 years.
Lauren Pulling, Neuro Central Editor, chats to Freya Leask about the latest updates from clinical trials for cell therapy for spinal cord injuries.
Could this new approach drive Parkinson’s disease into the age of personalized medicine?
We caught up with Regina Katzenschlager at AAN 2017, whose research into the use of apomorphine for Parkinson’s disease was highlighted at the conference as one to watch.
The use of on-a-chip technologies has seen enormous growth across the biomedical sciences in recent years, but how can this approach be harnessed to further understand dementia and develop new therapies?
Michael discusses his work, progress towards diagnosis of chronic traumatic encephalopathy in life and his thoughts on the latest in CTE research.
Dr Deer discusses his career highlights, most memorable patient cases, and looks ahead at future challenges and trends in the field of neuromodulation.
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis.